Remission and relapse of diabetes after sleeve gastrectomy and one‐anastomosis gastric bypass: The Tehran Obesity Treatment Study

Remission and relapse of diabetes after sleeve gastrectomy and one‐anastomosis gastric bypass: The Tehran Obesity Treatment Study

Aims To evaluate the rates and predictors of remission and relapse of type 2 diabetes mellitus (T2DM) in individuals with T2DM undergoing sleeve gastrectomy (SG) or one‐anastomosis gastric bypass (OAGB). Methods An observational prospective study with 5 years of follow‐up was conducted in a total of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes, obesity & metabolism obesity & metabolism, 2024-12, Vol.26 (12), p.6007-6015
Hauptverfasser: Sadeghi, Sara, Hosseinpanah, Farhad, Khalaj, Alireza, Ebadinejad, Amir, Mahdavi, Maryam, Valizadeh, Majid, Barzin, Maryam
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Anastomosis
Blood Glucose - analysis
Blood Glucose - metabolism
Body mass index
Diabetes
diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - surgery
Drug therapy
Female
Follow-Up Studies
Gastrectomy
Gastrectomy - methods
Gastric bypass
Gastric Bypass - methods
Gastrointestinal surgery
Glucose
Glycated Hemoglobin - analysis
Glycated Hemoglobin - metabolism
Hemoglobin
Humans
Insulin
Iran - epidemiology
Male
Middle Aged
Obesity
Obesity - complications
Obesity - surgery
Obesity, Morbid - complications
Obesity, Morbid - surgery
one‐anastomosis gastric bypass
Patients
Prospective Studies
Recurrence
relapse
Remission
Remission Induction
sleeve gastrectomy
Surgery
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims To evaluate the rates and predictors of remission and relapse of type 2 diabetes mellitus (T2DM) in individuals with T2DM undergoing sleeve gastrectomy (SG) or one‐anastomosis gastric bypass (OAGB). Methods An observational prospective study with 5 years of follow‐up was conducted in a total of 891 patients (82.5% female) with concomitant T2DM and obesity (body mass index ≥ 30.0 kg/m2) undergoing SG or OAGB between March 2013 and March 2021. T2DM remission was defined as achieving a glycated haemoglobin (HbA1c) level 
ISSN:1462-8902
1463-1326
1463-1326
DOI:10.1111/dom.15974